|
1
|
Chaturvedi P, Vaishampayan SS, Nair S, et
al: Oral squamous cell carcinoma arising in background of oral
submucous fibrosis: A clinicopathologically distinct disease. Head
Neck. Sep 13–2012.(Epub ahead of print). View Article : Google Scholar
|
|
2
|
Mehrotra D and Kumar S, Agarwal GG,
Asthana A and Kumar S: Odds ratio of risk factors for oral
submucous fibrosis in a case control model. Br J Oral Maxillofac
Surg. Aug 27–2012.(Epub ahead of print).
|
|
3
|
Khan S, Chatra L, Prashanth SK, Veena KM
and Rao PK: Pathogenesis of oral submucous fibrosis. J Cancer Res
Ther. 8:199–203. 2012. View Article : Google Scholar
|
|
4
|
Kothari MC, Hallur N, Sikkerimath B, Gudi
S and Kothari CR: Coronoidectomy, masticatory myotomy and buccal
fat pad graft in management of advanced oral submucous fibrosis.
Int J Oral Maxillofac Surg. 41:1416–1421. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ranganathan K and Kavitha R: Proliferation
and apoptosis markers in oral submucous fibrosis. J Oral Maxillofac
Pathol. 15:148–153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khan I, Agarwal P, Thangjam GS, Radhesh R,
Rao SG and Kondaiah P: Role of TGF-β and BMP7 in the pathogenesis
of oral submucous fibrosis. Growth Factors. 29:119–127. 2011.
|
|
7
|
Tadakamadla J, Kumar S and Mamatha GP:
Evaluation of serum copper and iron levels among oral submucous
fibrosis patients. Med Oral Patol Oral Cir Bucal. 16:e870–e873.
2011. View Article : Google Scholar
|
|
8
|
Wang YC, Tsai YS, Huang JL, et al:
Arecoline arrests cells at prometaphase by deregulating mitotic
spindle assembly and spindle assembly checkpoint: implication for
carcinogenesis. Oral Oncol. 46:255–262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee PH, Chang MC, Chang WH, et al:
Prolonged exposure to arecoline arrested human KB epithelial cell
growth: regulatory mechanisms of cell cycle and apoptosis.
Toxicology. 220:81–89. 2006.PubMed/NCBI
|
|
10
|
Lu SY, Chang KW, Liu CJ, Tseng YH, Lu HH,
Lee SY and Lin SC: Ripe areca nut extract induces G1
phase arrests and senescence-associated phenotypes in normal human
oral keratinocyte. Carcinogenesis. 27:1273–1284. 2006.PubMed/NCBI
|
|
11
|
Tu HF, Liu CJ, Chang CS, Lui MT, Kao SY,
Chang CP and Liu TY: The functional (−1171 5A→6A) polymorphisms of
matrix metalloproteinase 3 gene as a risk factor for oral submucous
fibrosis among male areca users. J Oral Pathol Med. 35:99–103.
2006.
|
|
12
|
Chiu CJ, Chiang CP, Chang ML, et al:
Association between genetic polymorphism of tumor necrosis
factor-alpha and risk of oral submucous fibrosis, a pre-cancerous
condition of oral cancer. J Dent Res. 80:2055–2059. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang LW, Hsieh BS, Cheng HL, Hu YC, Chang
WT and Chang KL: Arecoline decreases interleukin-6 production and
induces apoptosis and cell cycle arrest in human basal cell
carcinoma cells. Toxicol Appl Pharmacol. 258:199–207. 2012.
View Article : Google Scholar
|
|
14
|
Tsai YS, Lee KW, Huang JL, et al:
Arecoline, a major alkaloid of areca nut, inhibits p53, represses
DNA repair, and triggers DNA damage response in human epithelial
cells. Toxicology. 249:230–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mishra R and Das BR: Cyclin D1 expression
and its possible regulation in chewing tobacco mediated oral
squamous cell carcinoma progression. Arch Oral Biol. 54:917–923.
2009. View Article : Google Scholar
|
|
16
|
Liu L, Xie H, Chen X, Shi W, Xiao X, Lei D
and Li J: Differential response of normal human epidermal
keratinocytes and HaCaT cells to hydrogen peroxide-induced
oxidative stress. Clin Exp Dermatol. 37:772–780. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou Y, Zeng Z, Zhang W, et al:
Lactotransferrin: a candidate tumor suppressor-Deficient expression
in human nasopharyngeal carcinoma and inhibition of NPC cell
proliferation by modulating the mitogen-activated protein kinase
pathway. Int J Cancer. 123:2065–2072. 2008. View Article : Google Scholar
|
|
18
|
Zhou Y, Zeng Z, Zhang W, et al:
Identification of candidate molecular markers of nasopharyngeal
carcinoma by microarray analysis of subtracted cDNA libraries
constructed by suppression subtractive hybridization. Eur J Cancer
Prev. 17:561–571. 2008. View Article : Google Scholar
|
|
19
|
Kuo FC, Wu DC, Yuan SS, et al: Effects of
arecoline in relaxing human umbilical vessels and inhibiting
endothelial cell growth. J Perinat Med. 33:399–405. 2005.PubMed/NCBI
|
|
20
|
Bartek J, Lukas J and Bartkova J:
Perspective: defects in cell cycle control and cancer. J Pathol.
187:95–99. 1999. View Article : Google Scholar
|
|
21
|
Malumbres M: Cyclins and related kinases
in cancer cells. J BUON. 12(Suppl 1): S45–S52. 2007.
|
|
22
|
van den Heuvel S: Cell-cycle regulation.
WormBook. 1–16. 2005.
|
|
23
|
Chen HZ, Tsai SY and Leone G: Emerging
roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev
Cancer. 9:785–797. 2009.PubMed/NCBI
|
|
24
|
Kwong RA, Nguyen TV, Bova RJ, et al:
Overexpression of E2F-1 is associated with increased disease-free
survival in squamous cell carcinoma of the anterior tongue. Clin
Cancer Res. 9:3705–3711. 2003.
|
|
25
|
Luo X, Pan Q, Liu L, et al: Genomic and
proteomic profiling II: comparative assessment of gene expression
profiles in leiomyomas, keloids and surgically-induced scars.
Reprod Biol Endocrinol. 5:352007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calonge TM and O'Connell MJ: Turning off
the G2 DNA damage checkpoint. DNA Repair. 7:136–140.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyazaki T and Arai S: Two distinct
controls of mitotic cdk1/cyclin B1 activity requisite for cell
growth prior to cell division. Cell Cycle. 6:1419–1425. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu Y, Kovacevic Z and Richardson DR:
Tuning cell cycle regulation with an iron key. Cell Cycle.
6:1982–1994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakayama KI and Nakayama K: Ubiquitin
ligases: cell-cycle control and cancer. Nat Rev Cancer. 6:369–381.
2006. View Article : Google Scholar : PubMed/NCBI
|
